Cetuximab (added to chemotherapy, RAS Wild-Type)
Treatment for Colon And Rectum Cancer
Typical Dosage: Initial 400 mg/m2 IV, then 250 mg/m2 IV weekly (with chemotherapy)
Effectiveness
75%
Safety Score
35%
Clinical Trials
150
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
Initial 400 mg/m2 IV, then 250 mg/m2 IV weekly (with chemotherapy)
Time to Effect
1-3 months
Treatment Duration
Until progression
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$95,000
Monitoring:$17,000
Side Effect Mgmt:$15,000
Total Annual:$127,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$115,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$211,667
Cost per Remission
$2,540,000
Comparison vs FOLFIRI
Cost Difference
+$87,000/year
More expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Cetuximab (added to chemotherapy, RAS Wild-Type) Outcomes
for Colon And Rectum Cancer
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+60%
Remission Rate
+5%
Common Side Effects
Acne-like rash
+85%
Hypomagnesemia
+60%
Fatigue
+40%
Diarrhea
+25%
Infusion reactions
+4%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov